AMC

ASAHI KASEI MEDICAL (HANGZHOU) CO.,LTD. (referred to as AMC) was established on November 21, 2003, located in the national-level economic and technological development zone — Hangzhou Economic and Technological Development Zone. AMC belongs to Asahi Kasei Group, a well-known Japanese enterprise, and is an overseas subsidiary fully funded by Asahi Kasei Medical Co., Ltd., responsible for the medical device field. AMC has a total investment of 50.4 million US dollars and a registered capital of 20 million US dollars.Its main product is the hemodialyzer (commonly known as "artificial kidney"), an extracorporeal dialysis device used to treat patients with renal failure. AMC is the first production factory of "artificial kidneys" in mainland China, and its products are mainly exported to Japan, the United States, and the European market. It aims to become a production and sales base for global hemodialysis products, including in China.AMC aims to improve the quality of life of patients. According to market demand and business conditions, it continuously produces and develops new types of hemodialysis products, providing high-quality and internationally competitive products to domestic and foreign markets, contributing to the development of the global medical device industry.